AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q2 2024

Type / Class
Equity / COM
Symbol
AGLE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$16,449,840 0
2024 Q1 737,000 $16,449,840 +$16,449,840 $22.32 1
2023 Q4 0 $0 -$3,963,683 0
2023 Q3 318,486 $3,963,683 -$104,660,967 $12.25 3
2023 Q2 70,893,363 $31,935,431 +$15,515,777 $0.45 41
2023 Q1 41,322,133 $12,010,636 -$639,937 $0.29 42
2022 Q4 42,665,739 $19,222,238 -$1,385,022 $0.45 48
2022 Q3 44,703,377 $23,511,978 -$2,283,522 $0.53 48
2022 Q2 49,100,735 $24,801,289 -$2,471,956 $0.51 55
2022 Q1 41,451,901 $95,375,596 -$5,753,342 $2.30 79
2021 Q4 39,914,069 $189,433,755 -$3,823,133 $4.75 82
2021 Q3 40,575,589 $322,487,913 -$2,794,370 $7.95 75
2021 Q2 41,067,345 $285,826,747 -$3,346,363 $6.96 77
2021 Q1 41,503,533 $328,687,129 +$428,641 $7.92 82
2020 Q4 41,452,380 $326,223,019 +$18,161,948 $7.87 87
2020 Q3 38,820,318 $275,239,671 +$2,784,959 $7.09 90
2020 Q2 38,007,464 $351,556,699 +$162,094,753 $9.25 86
2020 Q1 20,599,999 $95,796,936 -$618,510 $4.66 67
2019 Q4 20,662,831 $157,857,334 -$1,662,540 $7.64 68
2019 Q3 20,081,184 $154,419,206 +$3,653,702 $7.69 70
2019 Q2 20,026,299 $137,050,926 +$765,179 $6.85 76
2019 Q1 19,749,035 $158,958,458 +$26,962,745 $8.05 69
2018 Q4 16,395,895 $122,855,000 +$5,763,437 $7.49 59
2018 Q3 14,651,774 $140,218,101 -$1,379,491 $9.57 58
2018 Q2 14,688,505 $155,412,639 +$65,826,338 $10.58 64
2018 Q1 8,475,547 $84,077,000 +$7,183,058 $9.92 37
2017 Q4 7,924,820 $42,872,000 +$824,141 $5.41 31
2017 Q3 7,802,397 $38,130,000 -$356,307 $4.93 31
2017 Q2 7,911,829 $30,437,000 +$10,514,320 $3.85 30
2017 Q1 5,168,489 $38,502,000 -$1,720,592 $7.45 23
2016 Q4 5,602,738 $24,370,000 -$2,420,936 $4.35 25
2016 Q3 5,928,539 $37,972,000 +$2,591,136 $6.41 28
2016 Q2 5,528,113 $26,634,000 +$26,633,997 $4.86 23